Emergency department management of patients with acute decompensated heart failure

Heart Failure Reviews

Volumn 9, Issue 3, 2005, Pages 187-193

  Peacock, W Franklin ^a   Emerman, Charles L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost containment; Emergency department; Heart failure; Nesiritide; Observation unit

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; MILRINONE; NESIRITIDE; VASOACTIVE AGENT;

ACUTE HEART FAILURE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOLOGY; CLINICAL OBSERVATION; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; EMERGENCY WARD; HEALTH CARE COST; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEMODYNAMIC MONITORING; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCOME; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDICAL SPECIALIST; NEPHROLOGY; PATIENT CARE; PULMONARY HYPERTENSION; REIMBURSEMENT; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 17144394437     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-005-6128-5     Document Type: Article

References (25)

1. Emerman CL, Peacock WF, for the ADHERE Scientific Advisory Committee and Investigators. Evolving patterns of care for decompensated heart failure: Implications from the ADHERE Registry Database [abstract 200] Acad Emerg Med 2004 11-503
2. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States (2001-2003): Rationale, design and preliminary observations from the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J (in press)
3. Maisel A. B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient. Rev Cardiovasc Med 2002 3 SUPPL 4 S10-S17
4. Emerman CL, DeMarco T, Costanzo MR, Peacock WF, for the ADHERE Scientific Advisory Committee. Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: Insights from the ADHERE Registry [abstract 368]. J Card Fail 2004 10 SUPPL 4 S116
5. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987 57 17-22
6. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985 103 1-6
7. Costanzo MR, Heywood JT, DeMarco T, Fonarow GC, Wynne JS. Impact of renal insufficiency and chronic diuretic therapy on outcome and resource utilization in patients with acute decompensated heart failure [abstract 1069-114]. J Am Coll Cardiol 2004 43 suppl A 180
8. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 2003 42 705-708 10.1016/S0735-1097(03)00765-4
9. Cuffe MS, Califf RM, Adams KFJ, et al., for the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 2002 287 1541-1547
10. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT Study. Am Heart J 2002 144 1102-1108
11. Silver MA, Horton DP, Ghali JK, Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 2002 39 798-803
12. Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel T, The ADHERE Scientific Advisory Committee and Investigators. Comparison of in-hospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: An analysis from a large prospective registry database [abstract 298]. J Card Fail 2003 9 suppl 1 S81
13. Peacock F, Emerman CL, Costanzo MR, Berkowitz RL, Cheng M, ADHERE Scientific Advisory Committee and Investigators. Early initiation of intravenous vasoactive therapy improves heart failure outcomes: An analysis from the ADHERE registry database [abstract 92]. Ann Emerg Med 2003 42 4 suppl S26
14. Peacock WF, Emerman CL, Wynne J, for the ADHERE Scientific Advisory Committee and Investigators, and the ADHERE Study Group. Early use of nesiritide in the emergency department is associated with improved outcome: An ADHERE registry analysis. Ann Emerg Med 2004 44(suppl 4) S78
15. Aghababian RV. Acutely decompensated heart failure: Opportunities to improve care and outcomes in the emergency department. Rev Cardiovasc Med 2002 3(suppl 4) S3-S9
16. American Heart Association, American Stroke Association. Heart Disease and Stroke Statistics-2004 Update. American Heart Association. Available at: http://www.americanheart.org/downloadable/heart/ 1072969766940HSStats2004Update.pdf. Accessed September 13, 2004.
17. Peacock WF, Allegra J, Ander D, et al. Management of acute decompensated heart failure in the emergency department. Congest Heart Fail 2003 9 (5 suppl 1) 3-18
18. Peacock WF. Acute emergency department management of heart failure. Heart Fail Rev 2003 8 335-338
19. Peacock WF, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am 2001 19 209-232
20. Peacock WF, Remer EE, Aponte J, Moffa DA, Emerman CE, Albert NM. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail 2002 8 68-73
21. Diercks DB, Kirk JD, Peacock WF, Weber JE. Identification of emergency department patients with decompensated heart failure at low risk for adverse events and prolonged hospitalization [abstract 376]. J Card Fail 2004 10(4 suppl) S118
22. Burkhardt J, Peacock WF, Emerman CL. Elevation in blood urea nitrogen predicts a lower discharge rate from the observation unit. Ann Emerg Med 2004 44 S99
23. Peacock WF, Albert NM. Patient outcome and costs following an acute heart failure (HF) management program in an emergency department (ED) observation unit (OU) [abstract 240]. J Heart Lung Transplant 1999 18 92
24. Peacock WF, Emerman CL, on behalf of the PROACTION Study Group. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients [abstract 1027-89]. J Am Coll Cardiol 2003 41(suppl A) 336A
25. Emerman CL, Peacock WF, Silver MA, on behalf of the PROACTION study group. Nesiritide added to standard care results in favorable reductions in systolic blood pressure and heart rate compared to standard care alone [abstract 221]. J Card Fail 2003 9(suppl) S61